TessArae Blog

News and Events from TessArae, LLC

TessArae, LLC Taps L. Thomas Richards, M.D. as President

POTOMAC FALLS, Va., June 8, 2011 /PRNewswire/ — TessArae®, LLC, a privately held company, today announced that it has appointed Tom Richards as its new President.  Dr. Richards has held faculty positions at Stanford University Medical Center and UCSF Medical Center, where he currently practices as an Assistant Clinical Professor in the Department of Emergency […]

Posted in News, Press Releases | No Comments

TessArae to Exhibit at 2011 Annual Clinical Genetics Meeting (ACMG)

Come and visit us at booth 120 at the 2011 ACMG meeting in Vancouver, BC Canada.  Learn about our GeneCipher™ Assay  for genetic disease testing. More information at the ACMG Conference Website.

Posted in News | No Comments

Dr. Matthew Lorence to Chair Session at Molecular Med Tri-Con 2011

Dr. Matthew Lorence, Vice President, Marketing and Sales for Tessarae, LLC will chair the Growth in Personalized Cancer Diagnostics session of the Cancer Molecular Markers program at Molecular Med Tri-Con 2011.  The session will be Friday February 25, 2011 at the Moscone North Convention Center, San Francisco, CA at 8:30am. 18th International Molecular Medicine Tri-Conference – […]

Posted in Meetings, News | No Comments

TessArae Awarded Contract by Massachusetts Department of Public Health

TessArae® was awarded a contract from the Massachusetts Department of Public Health for the purchase of DNA instrumentation, supplies, with support for validation, bioinformatics integration and training.  TessArae is a private company that designs and delivers the most cost-effective, highly multiplexed, targeted DNA sequencing diagnostics available on the market today, providing solutions for two key […]

Posted in News, Press Releases | No Comments

TessArae Partners with Israeli Testing Firm GGA to Design Cancer-Resequencing Chip

Expanding its activities in the genetic testing market, TessArae has partnered with an Israeli firm to design a resequencing microarray that can detect specific disease-causing mutations in 11 cancer genes. Kazerin-based Galil Genetic Analysis will next month launch the Affymetrix-made chip, according to officials from both companies. GGA CEO Yoram Plotsky told BioArray News this […]

Posted in News, Press Releases | No Comments

Klaus Schafer Selected to the Board of Directors of the Virginia Biotechnology Association (VABIO)

Dr. Klaus Schafer, President and CEO of TessArae, has been selected to serve on the board of directors of the Virginia Biotechnology Association. The Virginia Biotechnology Association (VABIO), formed in 1992, is the premier statewide non-profit trade association representing the life sciences industry in the Commonwealth of Virginia. Nearly 200 member organizations have joined forces […]

Posted in News, Press Releases, Uncategorized | No Comments

TessArae to Attend American Society for Human Genetics Meeting 2010

TessArae will be in attendance at the 60th Annual Meeting of the American Society of Human Genetics meeting in Washington, DC on November 2-6, 2010.  If you would like to speak to us, please contact us at: http://www.tessarae.com/contact.html. The TessArae Resequencing Diagnostic Microarray technology will also be discussed in a poster by Galil Genetic Analysis […]

Posted in Meetings, News | No Comments

Case Study Highlights TessArae Capabilities

TessArae Targeted Resequencing at GeneDx Provides More Comprehensive Analysis, Lower Cost, and Faster Results GeneDx is a premier genetic testing company that specializes in rare hereditary disorders. In 2008 the scientific team determined that they needed to update their testing method for Noonan Syndrome to enhance their competitive position in the market, and engaged in […]

Posted in News | No Comments

Matthew Lorence to Chair Session at Next Generation Dx Summit

The H1N1 epidemic has illuminated the need for new rapid molecular tests. Opportunities for point-of-care have arisen around the need for faster turnaround time and more sophisticated assays that differentiate strain types of emerging agents and that generate reliable results. This promises to improve healthcare delivery and make patient management more efficient with accurate diagnosis. […]

Posted in Uncategorized | No Comments

Dr. Agnieszka Lichanska to Present at BioConference Live 2010

Presentation Abstract: TessArae’s Resequencing Pathogen Microarray (RPM) simultaneously detects and identifies hundreds of strains of viral and bacterial pathogens. Unlike PCR and immunoassays that employ a surrogate marker for detection (e.g. fluorescent signal), RPM results are the nucleotide sequences of pathogen-specific signatures such as determinants of host-range, pathogenicity, virulence, and resistance to antiviral drugs, thus providing […]

Posted in Meetings, News | No Comments